Comprehensive analysis of the candidate genes CCL2, CCR2, and TLR4 in age-related macular degeneration.
暂无分享,去创建一个
R. T. Smith | C. Klaver | P. D. de Jong | R. Allikmets | A. Bergen | J. Merriam | J. Zernant | G. Barile | D. Despriet | I. Barbazetto | S. V. Soest | S. van Soest | A. Bakker | Paulus T. V. M. de Jong
[1] P. D. de Jong,et al. Comparison of human retinal pigment epithelium gene expression in macula and periphery highlights potential topographic differences in Bruch's membrane. , 2007, Molecular vision.
[2] T. Das,et al. Analysis of CFH, TLR4, and APOE polymorphism in India suggests the Tyr402His variant of CFH to be a global marker for age-related macular degeneration. , 2006, Investigative ophthalmology & visual science.
[3] Johanna M Seddon,et al. Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration , 2006, Nature Genetics.
[4] A. Hofman,et al. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. , 2006, JAMA.
[5] R. T. Smith,et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration , 2006, Nature Genetics.
[6] C. Sabatti,et al. Guidelines for association studies in Human Molecular Genetics. , 2005, Human molecular genetics.
[7] G. Abecasis,et al. Toll-like receptor 4 variant D299G is associated with susceptibility to age-related macular degeneration. , 2005, Human molecular genetics.
[8] R. T. Smith,et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[9] J. Gilbert,et al. Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration , 2005, Science.
[10] J. Ott,et al. Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.
[11] A. Edwards,et al. Complement Factor H Polymorphism and Age-Related Macular Degeneration , 2005, Science.
[12] I. Charo,et al. Chemokines in the pathogenesis of vascular disease. , 2004, Circulation research.
[13] D. Schwartz,et al. Toll-like receptors in the pathogenesis of human disease , 2004, Nature Immunology.
[14] Mardge H. Cohen,et al. CCR2 genotype and disease progression in a treated population of HIV type 1-infected women. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] Howard R. Petty,et al. Toll-Like Receptor 4 (TLR4) of Retinal Pigment Epithelial Cells Participates in Transmembrane Signaling in Response to Photoreceptor Outer Segments , 2004, The Journal of general physiology.
[16] S. Akira,et al. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[17] Eiji Sakurai,et al. An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice , 2003, Nature Medicine.
[18] John D. Storey,et al. Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[19] A. Hofman,et al. The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study. , 2003, Archives of ophthalmology.
[20] D. Rader,et al. Val64Ile Polymorphism in the C-C Chemokine Receptor 2 Is Associated With Reduced Coronary Artery Calcification , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[21] B. Rovin,et al. HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[22] F. Speleman,et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.
[23] H. Ullum,et al. Effects of CCR5- 32, CCR2-64I, and SDF-1 3A Alleles on HIV-1 Disease Progression: An International Meta-Analysis of Individual-Patient Data , 2001, Annals of Internal Medicine.
[24] Robert F. Mullins,et al. An Integrated Hypothesis That Considers Drusen as Biomarkers of Immune-Mediated Processes at the RPE-Bruch's Membrane Interface in Aging and Age-Related Macular Degeneration , 2001, Progress in Retinal and Eye Research.
[25] Z. Prohászka,et al. Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients. , 2001, Atherosclerosis.
[26] D. Schwartz,et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans , 2000, Nature Genetics.
[27] P T de Jong,et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration , 1995 .
[28] R. Medzhitov,et al. Toll-like receptors: linking innate and adaptive immunity. , 2004, Microbes and infection.
[29] H. Ullum,et al. Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data. , 2001, Annals of internal medicine.